relaxin mimetic azd5462
Generic: Relaxin Mimetic AZD5462
relaxin mimetic azd5462: 1 clinical trial tracked.
relaxin mimetic azd5462 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about relaxin mimetic azd5462, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
A Phase IIb Two-Cohort, Randomised, Placebo-controlled, Double-blind, Multi-centre, Dose-ranging Study of AZD5462 in Stable Patients With Chronic Heart Failure
Primary endpoint: Cohort A and B: Change from Baseline in Echocardiography Parameters
InterventionalRandomizeddouble375 enrolledStarted 2024-06Completion 2026-0250 sites · Bulgaria, Czechia, Denmark, Hungary…AstraZeneca